Ibrance 125 mg, Hartkapseln
7680661380036
CH-66138
Kapseln
Associated product:
IBRANCE caps 125 mg 21 pce
1 / 3
google
Article details
- Package size
- 21
- Selling units
- 21
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
125.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
92.958 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.13 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 2162.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2017
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 66138
- Drug name
- Ibrance, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L01EF01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 31/01/2017
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- IBRANCE caps 125 mg 21 pce
- Description (DE)
- IBRANCE Kaps 125 mg 21 Stk
- Market launch
- 31/01/2017
- Narcotic (BTM)
- No